WHO vaccine-preventable diseases: monitoring system. 2017 global summary

Last updated 06-Sep-2017 (data as of 05-Sep-2017)
Next overall update 2018
EPI mother and child logo         
Select a country

Development status: Developed economy GNI / capita (US$): 54'9601 Infant (under 12 months) mortality rate: 62
GDP / capita (US$): 55'8371 Child (under 5 years) mortality rate: 72

Population data in thousands3

  2016  2015  2014  2013  2012  2000  1990  1980 
Total population 322'180  319'929  317'719  315'537  313'335  281'983  252'530  229'763 
Births 4'040  4'003  3'979  3'971  3'982  3'966  3'960  3'438 
Surviving infants 4'018  3'980  3'956  3'948  3'957  3'938  3'922  3'395 
Pop. less than 5 years 19'607  19'851  19'969  20'214  20'508  19'589  19'277  16'609 
Pop. less than 15 years 61'305  61'468  61'571  61'756  61'981  61'191  54'759  52'132 
Female 15-49 years 73'900  73'662  73'522  73'407  73'307  71'270  66'029  58'609 

Number of reported cases

(Click for retrospective incidence data for United States of America (the))
Diphtheria
ChartChart
 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  188  667  187  55  85  27'786  13'506 
Mumps
ChartChart
  1'308  1'223  584  229  323 
Pertussis
ChartChart
  20'679  32'971  28'639  48'277  7'867  4'570  1'730 
Polio*
ChartChart
 
Rubella
ChartChart
  176 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
  30  25  26  37  35  64  95 
Yellow fever
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for United States of America (the))
Vaccine year result method % card seen                                                
BCG         
DTP1          98  98  98  98  97  99* 
DTP3          95  95  95  94  94  94  96 
DTP4          85  84 
IPV1          97  97 
HepB_BD          64  72  72  74  72 
HepB3          93  92  92  91  90  90 
Hib3          93  93  93  93  93  93 
JapEnc         
MCV1          92  92  92  92  91  91  86 
MCV2         
MenA         
PCV1          97  97  97 
PCV2          96  95  95 
PCV3          93  93  93  92  92 
Pol3          94  93  93  93  93  90  95 
Rota1          88  87  83 
RotaC          73  72  72  73  69 
RCV1          92  92  91 
TT2plus          49 
PAB         
VAD1         
YFV         
* indicates the country reported above 100% coverage.

  Next update: Mid-July 2018

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for United States of America (the))
DTP1
ChartChart
  97  97  97  97  96  99  96  98 
DTP3
ChartChart
  95  95  95  94  94  94  90  96 
HepB3
ChartChart
  93  92  92  91  90  90 
HepB_BD
ChartChart
  64  72  72  74  72 
Hib3
ChartChart
  93  93  93  93  93  93 
MCV1
ChartChart
  92  92  92  92  91  91  90  86 
MCV2
 
PCV3
ChartChart
  93  93  93  92  92 
Pol3
ChartChart
  94  93  93  93  93  90  85  95 
RCV1
ChartChart
  92  92  92  92  91  91  90  86 
RotaC
ChartChart
  73  72  72  73  69 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
 
   
/
|
|
\
Greater or equal to 90%
From 80 to 89%
From 50 to 79%
Less than 50%
Proportion of districts
not reporting DTP3 coverage
100
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2016 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
DT 2, 4, 6, >15 months; >4 years; Yes
DTaP 2, 4, 6, > 15 months; > 4 years; Yes
DTaPHepBIPV 2, 4, 6 months; Yes
DTaPHibIPV 2, 4, 6 months; Yes
DTaPIPV > 4 years (x2); Yes
HepA_Adult 10 years; Yes
HepA_Pediatric 12, >18 months; Yes
HepB_Adult 19 years; Yes
HepB_Pediatric 1st contact; +2, +6 months; Yes
Hib 2, 4, 6, > 12 months; Yes
HPV >11 years (x3 doses); Yes
Influenza_Adult Yes elderly, adults with chronic diseases, pregnant women, health care workers, and other risk groups
Influenza_Pediatric Yes and children with chronic diseases
IPV 2, 4, > 6 months; > 4 years; Yes
MenACWY >11, >16 years; Yes
MenB > 10 years; (x3) Yes
MMR 12 months; 4 years; Yes
Pneumo_conj 2, 4, 6, >12 months; Yes
Pneumo_ps 65 years; Yes
Rotavirus 2, 4, 6 months; Yes
Td Yes recommended every 10 year
Tdap 11 years; Yes Also recommended for adult with no prior Tdap vaccination and for child 7yrs and older with incomplete pertussis vacciantion
Varicella >12 months; 4 years; Yes
Zoster 60 years; Yes

Immunizaton indicators

Indicator Expected answer 2016  2015  2014  2013  2012  2011  2010 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR   No  No         
What years does the MYP cover? number         Yes     
Nº of districts with microplans that include activities to raise immunization coverage number              

System performance

Total Nº districts in country number              
Nº districts with DTP3 coverage >=80% number      
% of districts with DTP3 coverage >=80% From 0 to 100%              
Nº districts with measles (MCV1) coverage >=95% number      
% of districts with MCV1 coverage >=95% From 0 to 100%              

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND   Yes           
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR   Yes      Yes     

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100%              

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes      Yes 

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2015
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.